SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: JOHN W. who wrote (2466)10/24/1997 12:51:00 AM
From: billkirn  Read Replies (1) | Respond to of 6136
 
John: I thought Roche has studied the combo of Nelfinavir and saquinavir for some time. I thought that was a big reason Roche obtained the European rights to Nelfinavir. Do you know if any reports are planned on these studies in the near future?
Bill



To: JOHN W. who wrote (2466)10/24/1997 6:29:00 PM
From: BarryH  Read Replies (4) | Respond to of 6136
 
John, it broke down through 51 today on a day that most biotech weren't hurt bad..quite frankly I'm worried..

Anybody have any ideas as to what's going on?

BarryH